Effects of Limosilactobacillus reuteri ID-D01 Probiotic Supplementation on Exercise Performance and Gut Microbiota in Sprague-Dawley Rats
Probiotics and Antimicrobial Proteins · 2025
DOI: 10.1007/s12602-024-10257-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Ye-Ji Jang und 4 weiteren Autor:innen. Beteiligte Einrichtung: YUNOVIA Co., Ltd, Hwaseong, 18449, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Physical Conditioning, Animal, Limosilactobacillus reuteri. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
The gut microbiota composition in animals and humans has recently been found to be influenced by exercise. Although Limosilactobacillus reuteri strains have notable probiotic properties that promote human health, understanding of its effects in combination with exercise and physical activity is limited. Therefore, this study examined the effects of L. reuteri ID-D01, a human-derived probiotic, on exercise performance and fatigue in Sprague-Dawley rats. Organ weight, maximal running distance, serum biochemistry, muscle performance, microbial community composition, and short-chain fatty acid (SCFA) levels were assessed. Results indicated that ID-D01 supplementation significantly improved endurance performance. Rats in the probiotic group demonstrated a significant increase in maximal running distance compared with that in the control group ( p < 0.05). Additionally, levels of fatigue markers, such as lactate and creatine phosphokinase, were significantly reduced in the ID-D01-administered groups, suggesting its potential to alleviate exercise-induced fatigue. Microbiome analysis revealed a distinct shift in gut microbiota composition in response to ID-D01 administration. The group that received ID-D01 probiotics exhibited a significant increase in the abundance of SCFA-producing bacteria, particularly Akkermansia spp., compared with that in the control groups. Furthermore, they showed elevated production of SCFAs, such as acetate and butyrate. In conclusion, this study demonstrated that ID-D01 can enhance exercise performance and reduce fatigue. Herein, we highlighted that human-derived probiotics could improve physical performance, as observed by changes in gut microbiota composition and SCFA production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- YUNOVIA Co., Ltd, Hwaseong, 18449, Republic of Korea.
- YUNOVIA Co., Ltd, Hwaseong, 18449, Republic of Korea. jsmoon@ildong.com.
- Ildong Pharmaceutical Co., Ltd, Seoul, 06752, Republic of Korea. jsmoon@ildong.com.
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Jang, Y. J., Choi, H. S., Oh, I., Chung, J. H., & Moon, J. S. (2025). Effects of Limosilactobacillus reuteri ID-D01 Probiotic Supplementation on Exercise Performance and Gut Microbiota in Sprague-Dawley Rats. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-024-10257-9
Vancouver
Jang YJ, Choi HS, Oh I, Chung JH, Moon JS. Effects of Limosilactobacillus reuteri ID-D01 Probiotic Supplementation on Exercise Performance and Gut Microbiota in Sprague-Dawley Rats. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-024-10257-9
BibTeX
@article{Jang2025,
author = {Jang, Ye-Ji and Choi, Han Sol and Oh, Ikhoon and Chung, Jae Hyuk and Moon, Jin Seok},
title = {Effects of Limosilactobacillus reuteri ID-D01 Probiotic Supplementation on Exercise Performance and Gut Microbiota in Sprague-Dawley Rats},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
doi = {10.1007/s12602-024-10257-9}
}
EUVIMED